343 related articles for article (PubMed ID: 26134383)
1. Latest advances in molecular topology applications for drug discovery.
Zanni R; Galvez-Llompart M; García-Domenech R; Galvez J
Expert Opin Drug Discov; 2015; 10(9):945-57. PubMed ID: 26134383
[TBL] [Abstract][Full Text] [Related]
2. Molecular topology as a novel approach for drug discovery.
Gálvez J; Gálvez-Llompart M; García-Domenech R
Expert Opin Drug Discov; 2012 Feb; 7(2):133-53. PubMed ID: 22468915
[TBL] [Abstract][Full Text] [Related]
3. Quantitative structure-activity relationship: promising advances in drug discovery platforms.
Wang T; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2015 Dec; 10(12):1283-300. PubMed ID: 26358617
[TBL] [Abstract][Full Text] [Related]
4. Advances in the molecular modeling and quantitative structure-activity relationship-based design for antihistamines.
Galvez J; Galvez-Llompart M; Zanni R; Garcia-Domenech R
Expert Opin Drug Discov; 2013 Mar; 8(3):305-17. PubMed ID: 23289365
[TBL] [Abstract][Full Text] [Related]
5. On the contribution of molecular topology to drug design and discovery.
Gálvez J; García-Doménech R
Curr Comput Aided Drug Des; 2010 Dec; 6(4):252-68. PubMed ID: 20883200
[TBL] [Abstract][Full Text] [Related]
6. QSAR methods for the discovery of new inflammatory bowel disease drugs.
García-Domenech R; Gálvez-Llompart M; Zanni R; Recio MC; Gálvez J
Expert Opin Drug Discov; 2013 Aug; 8(8):933-49. PubMed ID: 23668227
[TBL] [Abstract][Full Text] [Related]
7. Multitasking models for quantitative structure-biological effect relationships: current status and future perspectives to speed up drug discovery.
Speck-Planche A; Cordeiro MN
Expert Opin Drug Discov; 2015 Mar; 10(3):245-56. PubMed ID: 25613725
[TBL] [Abstract][Full Text] [Related]
8. What place does molecular topology have in today's drug discovery?
Zanni R; Galvez-Llompart M; Garcia-Domenech R; Galvez J
Expert Opin Drug Discov; 2020 Oct; 15(10):1133-1144. PubMed ID: 32496823
[TBL] [Abstract][Full Text] [Related]
9. The application of molecular topology for ulcerative colitis drug discovery.
Bellera CL; Di Ianni ME; Talevi A
Expert Opin Drug Discov; 2018 Jan; 13(1):89-101. PubMed ID: 29088918
[TBL] [Abstract][Full Text] [Related]
10. QSAR studies in the discovery of novel type-II diabetic therapies.
Abuhammad A; Taha MO
Expert Opin Drug Discov; 2016; 11(2):197-214. PubMed ID: 26558613
[TBL] [Abstract][Full Text] [Related]
11. The advancement of multidimensional QSAR for novel drug discovery - where are we headed?
Wang T; Yuan XS; Wu MB; Lin JP; Yang LR
Expert Opin Drug Discov; 2017 Aug; 12(8):769-784. PubMed ID: 28562095
[TBL] [Abstract][Full Text] [Related]
12. QSAR and 3D-QSAR studies applied to compounds with anticonvulsant activity.
Garro Martinez JC; Vega-Hissi EG; Andrada MF; Estrada MR
Expert Opin Drug Discov; 2015 Jan; 10(1):37-51. PubMed ID: 25297377
[TBL] [Abstract][Full Text] [Related]
13. Recent advances on the role of topological indices in drug discovery research.
Estrada E; Uriarte E
Curr Med Chem; 2001 Nov; 8(13):1573-88. PubMed ID: 11562286
[TBL] [Abstract][Full Text] [Related]
14. Rational drug design for anti-cancer chemotherapy: multi-target QSAR models for the in silico discovery of anti-colorectal cancer agents.
Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
Bioorg Med Chem; 2012 Aug; 20(15):4848-55. PubMed ID: 22750007
[TBL] [Abstract][Full Text] [Related]
15. Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.
González-Díaz H; Romaris F; Duardo-Sanchez A; Pérez-Montoto LG; Prado-Prado F; Patlewicz G; Ubeira FM
Curr Pharm Des; 2010; 16(24):2737-64. PubMed ID: 20642428
[TBL] [Abstract][Full Text] [Related]
16. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
[TBL] [Abstract][Full Text] [Related]
17. QSAR multi-target in drug discovery: a review.
Zanni R; Gálvez-Llompart M; Gálvez J; García-Domenech R
Curr Comput Aided Drug Des; 2014; 10(2):129-36. PubMed ID: 24724898
[TBL] [Abstract][Full Text] [Related]
18. Role of computer-aided drug design in modern drug discovery.
Macalino SJ; Gosu V; Hong S; Choi S
Arch Pharm Res; 2015 Sep; 38(9):1686-701. PubMed ID: 26208641
[TBL] [Abstract][Full Text] [Related]
19. Introduction to molecular topology: basic concepts and application to drug design.
Gálvez J; Gálvez-Llompart M; García-Domenech R
Curr Comput Aided Drug Des; 2012 Sep; 8(3):196-223. PubMed ID: 22734705
[TBL] [Abstract][Full Text] [Related]
20. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
